Fluorescent proteins (FPs) are extremely useful tools for whole-cell, tissue, and animal labeling. For these purposes, FPs may be monomeric or oligomeric, but should meet the criteria of being tolerated at high expression levels in cells and having desirable photophysical properties.
INTRODUCTION
FPs are used in two main applications: as whole-cell labels and as fusion tags 1 . An FP employed as a whole-cell label can be either oligomeric or monomeric, but an FP employed as a fusion tag should ideally be monomeric. Green FPs are available for both applications. For example, enhanced GFP (EGFP) or its fully monomeric derivative mEGFP (containing the A206K mutation 2 ) can be used either as whole-cell labels or as fusion tags.
To generate red FP whole-cell labels, oligomeric FPs have been engineered to improve their fluorescence properties. Wild-type (WT) DsRed suffers from slow chromophore maturation, but this problem was overcome by creating the rapidly maturing variants DsRed.T1 (also known as DsRed-Express), DsRed.T3, and DsRed.T4 3 . More recently, eqFP578 was modified to create oligomeric variants such as TurboRFP, which has red emission 4 , and Katushka, which has far-red emission 5 . Similarly, eqFP611 was modified to create oligomeric variants such as RFP611 6 . To generate red FP fusion tags, oligomeric FPs have been converted to monomers. Derivatives of DsRedExpress include DsRed-Monomer 7 , as well as mCherry and related "mFruits" such as the pseudo-monomeric tandem dimer tdTomato 8 . Kusabira-Orange was modified to generate mKO2 9 . TurboRFP was modified to generate TagRFP 4 and the more photostable TagRFP-T 10 , and Katushka was modified to generate mKate 5 . Despite this abundance of options, red FPs have seen only limited usage as whole-cell labels, particularly when the application involves stable expression in cell lines or transgenic organisms. One reason is cytotoxicity. Whole-cell labeling is typically achieved using strong promoters, and cells containing high levels of FPs may show growth defects and/or instability of the FP markers DsRed-Express was an unstable marker that inhibited cell growth 12 . We therefore set out to evaluate the existing red FPs as whole-cell labels, and to engineer an improved red FP for this purpose.
RESULTS

Evaluation of red FPs as whole-cell labels
For whole-cell labeling with an FP, two criteria are relevant. First, the cells should tolerate high cytosolic levels of the FP. Second, the FP should have favorable fluorescence properties such as rapid maturation, high brightness, and high photostability. We used these criteria to evaluate 11 oligomeric or monomeric red FPs, plus mEGFP as a reference.
To assess cytotoxicity in E. coli, cells were transformed with a standard plasmid in which FP expression is induced using isopropyl-β-D-thiogalactopyranoside (IPTG). In the presence of IPTG, large colonies were obtained only with mEGFP (Fig. 1a) . Medium size colonies were obtained with DsRed-Monomer, and small colonies were obtained with DsRed-Express. Very small colonies were obtained with mCherry, TagRFP, and TagRFP-T. Tiny "pinprick" colonies were seen with tdTomato, mKO2, TurboRFP, Katushka, mKate, and RFP611. We conclude that many red FPs show moderate to severe cytotoxicity in E. coli.
To assess cytotoxicity in mammalian cells, HeLa cells were transiently transfected with a standard plasmid in which FP expression is driven by the CMV promoter. The viable fluorescent cells were analyzed at daily intervals by flow cytometry. For mEGFP, average cellular fluorescence remained nearly constant until 120 h (Fig. 1b) . By contrast, all of the red FPs showed progressive declines in average fluorescence (Fig. 1b) , with the declines ranging from gradual for DsRed-Express to steep for RFP611 and Katushka. This phenomenon reflected a preferential loss of highly expressing cells, as indicated by comparing the distributions of cellular fluorescence intensities at 24 h versus 120 h after transfection (data not shown). We conclude that at high expression levels, all of the red FPs tested are cytotoxic to HeLa cells. Table 1 lists key fluorescence properties of the red FPs. All of them except DsRed-Monomer showed reasonable intrinsic brightness. DsRed-Express, Katushka, and mCherry showed the fastest maturation, while maturation of the other FPs was significantly slower. To assess photostability, we devised a simple assay to mimic the typical experience for many researchers. Photostability during widefield imaging was measured using an epifluorescence microscope with a fixed light intensity and a Texas Red filter set. In agreement with a recent study 5 , DsRed-Express was by far the most photostable of the red FPs tested.
Based on these results, DsRed-Express showed the most promising combination of moderate cytotoxicity and desirable fluorescence properties. We therefore set out to engineer a less cytotoxic derivative of DsRedExpress.
Generation of improved DsRed tetramers
The cytotoxicity of red FPs may stem from aggregation 12, 14 . Protein aggregates are the toxic species in diseases of protein folding, but cytotoxic aggregates can be quite small 15 , so FP aggregates might be hard to detect by microscopy. As an alternative, we used an assay in which bacteria expressing an FP are grown in 96-well plates, then lysed and centrifuged 3 . Quantitation of fluorescence in the pellet provides a measure of aggregation. Empirically, this assay gives much stronger signals for oligomeric than for monomeric FPs, presumably because oligomers are multivalent and thus prone to form larger aggregates. We therefore compared the monomeric FPs to one another, and similarly for the oligomeric FPs. Among the monomers (Fig. 2a) , mEGFP, DsRed-Monomer, and mCherry yielded a background signal of 3-4% fluorescence in the pellet. The remaining monomers showed detectable aggregation, with fluorescence in the pellet ranging from 6-7% for tdTomato and mKO2 to 12-15% for TagRFP, TagRFP-T, and mKate. We infer that many of the ostensibly monomeric red FPs actually exhibit residual self-association. All of the oligomers showed substantial aggregation (Fig. 2b) , with the fluorescence in the pellet ranging from 35-60% for DsRed-Express, Katushka, and RFP611 to nearly 100% for TurboRFP.
Our goal was to reduce the higher-order aggregation of DsRed-Express. Based on our earlier work with DsRed-Monomer 7 , we introduced ten substitutions to stabilize the protein and eliminate potentially interactive surface residues. The resulting variant was termed Round 1. With the bacterial extraction assay, the Round 1 variant showed a small but reproducible decrease in aggregation (data not shown).
To identify additional residues that promote aggregation, we reasoned that inter-tetramer interactions might be visible in the high-concentration environment of a protein crystal. Packing interactions in published DsRed crystal structures 7, [16] [17] [18] were analyzed with the Protein Interfaces, Surfaces and Assemblies (PISA) server 19 . Certain residues were consistently found to make inter-tetramer contacts. For example, Gln188 was present in crystal packing interfaces for both WT DsRed 18 and DsRed.T4 7 . In the DsRed.T4 crystal, Gln188 has a symmetric interaction with another Gln188 from an adjacent tetramer (Fig. 3a) , so substituting a charged residue at position 188 might inhibit aggregation via charge-charge repulsion. Indeed, the Q188K mutation caused a 10% decrease in pellet fluorescence (data not shown). Sixteen residues identified using PISA were mutagenized combinatorially with Round 1 as the template. The substitutions E10P, R17H, and Q188K reduced aggregation. These three substitutions were combined to create the Round 2 variant, which had ~15% of its fluorescence in the pellet (data not shown).
Round 2 was then subjected to random mutagenesis 20 followed by screening with the bacterial extraction assay. This screen led to the substitutions N3S and E168K, both of which reverted mutations that had been introduced into Round 1. The resulting variant, which we termed DsRed-Express2, had only 3-4% of its fluorescence in the pellet (Fig. 3b) . Bacteria expressing DsRed-Express2 produced large colonies similar to those obtained with mEGFP ( Fig. 3c) .
Compared to DsRed-Express, DsRed-Express2 showed almost identical brightness, marginally slower maturation, and less contaminating blue absorbance and green emission ( Table 1) . DsRed-Express2 retained the high photostability of DsRed-Express during either widefield or confocal imaging ( Table 1) . Thus, DsRed-Express2 combines the favorable fluorescence properties of DsRed-Express with stronger bacterial expression, reduced aggregation, and minimal cytotoxicity in E. coli.
Cytotoxicity in HeLa cells
Does DsRed-Express2 also show low cytotoxicity in mammalian cells? We addressed this question using the transient transfection assay. As with mEGFP, the cultures expressing DsRed-Express2 maintained a nearly constant average fluorescence (Fig. 4a) and did not lose the highly expressing cells. These results indicate that DsRedExpress2 is tolerated better by HeLa cells than any of the other red FPs tested.
An alternative to transient transfection is retroviral transduction, which yields relatively stable expression at moderate levels 21 . We used a commercial lentiviral system to compare DsRed-Express2 with DsRed-Express, plus mEGFP as a reference. HeLa cells were transduced using the same lentiviral titer for each FP. Viable fluorescent cells were then counted by flow cytometry at 72 h post-transduction (Day 0). We reproducibly found that about three times as many fluorescent HeLa cells were obtained with DsRed-Express2 as with DsRed-Express (Fig. 4b) . Moreover, the fluorescent cells containing DsRed-Express2 were about twice as bright on average as those containing DsRed-Express (Fig. 4c) , even though the intrinsic brightness of the two proteins is identical. Thus, by 72 h post-transduction, the cells containing high levels of DsRed-Express had apparently been lost from the population.
We continued to track cellular fluorescence over the course of a 9-day growth period. The average brightness of cells expressing DsRed-Express progressively decreased to ~70% of the Day 0 value, whereas the average brightness of cells expressing DsRed-Express2 or mEGFP remained above 90% of the Day 0 value (Fig.  4d) . In a separate experiment, lentivirally transduced HeLa cells containing DsRed-Express showed a lag in growth relative to cells containing DsRed-Express2 or mEGFP (Fig. 4e) . These results confirm that in HeLa cells, DsRed-Express2 is much less cytotoxic than DsRed-Express.
Cytotoxicity in murine hematopoietic stem and progenitor cells
We wanted to determine whether the low cytotoxicity of DsRed-Express2 would be relevant in a realistic experimental context. A suitable test was suggested by a report 12 in which murine bone marrow cells were retrovirally transduced to express either EGFP or DsRed-Express, and were then grown in vitro under culture conditions that favored the preservation and growth of hematopoietic stem and progenitor cells. The cells containing EGFP grew robustly while those containing DsRed-Express did not.
To test if DsRed-Express2 would be tolerated better than DsRed-Express, murine bone marrow cells were retrovirally transduced with DsRed-Express, DsRed-Express2, or EGFP. Viable fluorescent cells were collected by flow cytometry at 87 h post-transduction (Day 0), and then individual cultures were started with 20,000 cells. For each culture we recorded the total cell number and the percentage of fluorescent cells after 3, 6, and 10 days. At Day 0, the cells containing DsRed-Express2 were more abundant, and were on average twice as bright as those containing DsRed-Express (Fig. 5a) . The cells containing DsRed-Express2 proliferated to the same degree as those containing EGFP, but the cells containing DsRed-Express proliferated significantly less (Fig. 5b) . These data with hematopoietic stem and progenitor cells are remarkably similar to the results with HeLa cells. We conclude that DsRed-Express2 is minimally cytotoxic in mammalian systems.
DISCUSSION
The utility of red FPs is compromised by cytotoxicity, which probably stems from aggregation. This problem was overcome by identifying mutations that reduced the aggregation of tetrameric DsRed to negligible levels, thereby generating DsRed-Express2.
As anticipated, the less aggregation-prone DsRed tetramers show substantially reduced cytotoxicity. In E. coli cells, colonies containing DsRed-Express2 are larger than those containing any of the other red FPs tested. In mammalian cells, DsRed-Express2 is unique among the red FPs tested in preserving cell viability at high expression levels. Thus, even though some red FPs are intrinsically brighter than DsRed-Express2, the in vivo fluorescence signal from DsRed-Express2 can be stronger and more persistent.
DsRed-Express2 has additional advantages. It is excited efficiently by both the blue and green lasers that are routinely used in flow cytometers, and it has very low green emission. Unlike many other red FPs, which photobleach rapidly during time-lapse imaging, DsRed-Express2 is very photostable. Another important property is phototoxicity. FPs can be phototoxic upon illumination, presumably due to production of reactive oxygen species 22, 23 , but phototoxicity has not often been measured for engineered FPs. Our results indicate that DsRed-Express2 has low phototoxicity 24 . Thus, for applications that involve whole-cell imaging, DsRed-Express2 seems to be the red FP of choice.
DsRed-Express2 is likely to be well tolerated as a whole-cell label in transgenic organisms. Although the previously available red FPs have been used successfully to generate fluorescently labeled insects 25 and vertebrates 5, [26] [27] [28] [29] , those findings probably reflect a threshold effect in which a cytotoxic FP is tolerated up to a certain concentration. We suspect that the transgenes in earlier studies were expressed at relatively low levels and may sometimes have caused residual cytotoxicity. DsRed-Express2 should facilitate the production of healthy transgenic organisms with strong and stable red fluorescence. Similar improvements can be expected for procedures in which fluorescently labeled cells are transplanted into animal hosts 30 . For example, when retrovirally transduced mouse hematopoietic stem cells were transplanted into mice, cells expressing EGFP were maintained whereas those expressing DsRed-Express were progressively lost 12 . This result suggests that cytotoxicity studies with cultured cells can predict the behavior of an FP in vivo.
Because DsRed-Express2 is tetrameric, it is suitable for labeling the cytosol or the interior of organelles such as the nucleus. However, only monomeric FPs are suitable for making fusion proteins. The systematic approach described here could be adapted to eliminate any remaining self-association of monomeric red FPs.
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METHODS
Expression of FPs in E. coli
FP genes were subcloned into E. coli expression vectors (Qiagen). pQE-81 was used to add an N-terminal hexahistidine tag. A derivative of pQE-60 termed pQE-60NA was used to express an untagged FP from its endogenous start codon. In strains containing the lacI q gene, expression was induced by adding 1 mM IPTG.
FP cytotoxicity in bacteria was examined as follows. For Fig. 1a , E. coli DH10B cells containing the repressor plasmid pREP4 (Qiagen) were transformed with pQE-60NA encoding the relevant FP. Each transformation mixture was split in half and spread on sectors of two Luria broth (LB) plates containing 50 μg/ml carbenicillin plus 30 μg/ml kanamycin, and either lacking or containing 1 mM IPTG. The plates were incubated for 14 h at 37 o C. For Fig. 3c , DH10B cells were transformed with pQE-60NA encoding the relevant FP, and the transformants were plated on adjacent sectors of an LB plate containing 100 µg/ml ampicillin. After growth for 14 h at 37 o C, the plate was stored at 4 o C for 2 days to enhance colony color.
HeLa cell cytotoxicity and growth assays
For the transient transfection assays, the desired FP gene was subcloned into pDsRed1-N1 (Clontech). Fifteen identical wells of HeLa cells at ~50% confluence were transfected using Lipofectamine 2000 (Invitrogen). At intervals of 24 h after transfection, three wells for each FP were analyzed with an LSR II flow cytometer (BD Biosciences), using either a 488-nm laser for mEGFP or a 543-nm laser for the red FPs. Between 20-50% of the viable cells were detectably fluorescent at 24 h after transfection. Data were processed using FlowJo software (Treestar Inc.).
For the lentiviral expression assays, HeLa cells expressing the desired FP were generated by lentiviral gene transfer using the Lenti-X HT Packaging System with associated vectors (Clontech). An FP gene with a Kozak sequence upstream of the start codon was subcloned into pLVX-DsRed-Monomer between BamHI and NotI. pLVX-Puro was used as a no-insert control. To generate viral particles, HEK 293T/17 cells (ATCC No. CRL-11268) in a 10-cm dish at 50% confluence were transfected with ~6 μg of the appropriate vector. Viral particles were collected 48-72 h post-transfection and frozen in aliquots at -80 o C. Viral particle concentration was determined using the QuickTiter Lentivirus Quantitation Kit (Cell Biolabs). A 10-cm dish of HeLa cells at 50% confluence were transduced by adding 2.3 x 10 10 viral particles to the medium together with polybrene (4 μg/ml final concentration). The medium was changed after 24 h. Viable fluorescent cells were collected at 72 h posttransduction using a FacsAria flow cytometer (BD Biosciences) with 488-nm excitation and a FITC (green fluorescence) or PE (red fluorescence) filter. Cells were then cultured in the absence of drug selection.
To measure the expression stability of a given FP after lentiviral transduction, 120,000 fluorescent HeLa cells were cultured in each of three wells in a 6-well dish. Every 3 days, half of the cells from each well were passaged, and the other half were analyzed with an LSR II flow cytometer using 488-nm excitation and a FITC or PE filter. Data were processed using FACSDiva software (BD Biosciences).
To measure the growth of cells expressing a given FP after lentiviral transduction, 3000 fluorescent HeLa cells were cultured in each of 12 wells in a 96-well plate. On Days 1, 2, 3, and 4, cells from three wells were trypsinized and counted with a hemocytometer. As a control, viable cells were cultured and counted after transduction with lentiviral particles generated using pLVX-Puro.
Hematopoietic stem and progenitor cell growth assay
This assay was carried out essentially as described 12 . Briefly, murine stem cell virus-based bicistronic retroviral constructs encoding EGFP, DsRed-Express, or DsRed-Express2 were transfected into the Phoenix-Eco packaging cell line to make ecotropic retroviral vectors. Low-density bone marrow mononuclear cells isolated from 8-to 12-week-old female C57BL/6J mice were cultured for 2 days with a cytokine cocktail (100 ng/ml murine stem cell factor, 100 ng/ml murine FLT3-ligand, and 100 ng/ml murine thrombopoietin) and then transduced with the retroviral vectors. At 87 h after transduction, the cells were sorted by flow cytometry. For each FP, three wells with 20,000 fluorescent cells each were cultured in the presence of the cytokine cocktail. At selected time points, an aliquot from each well was analyzed by flow cytometry to determine total cell number and the percentage of fluorescent cells. The methods for the aggregation assay, optimization of DsRed expression, library construction and screening, the brightness screens, the photobleaching assays, the phototoxicity assays, and FP purification and analysis are found in Ref. 24 . f The initial report describing mCherry and tdTomato listed substantially faster maturation rates 8 . Our measurement for mCherry is more consistent with a subsequent paper 4 .
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